Nulojix - supply shortage

Resolved

belatacept

Shortage information

The shortage affecting Nulojix has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Nulojix
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  belatacept
• Therapeutic area (MESH):
  • Graft Rejection
  • Kidney Transplantation
• Pharmaceutical forms affected:
  Solution for infusion
• Strengths affected:
  25 mg/ml

Key dates

• First published:
  17/03/2017
• Last updated:
  03/10/2023